The vaccine should be administered by intramuscular injection. The preferred injection site is the deltoid muscle of the shoulder or the anterolateral area of the upper thigh.
The drug cannot be administered intravenously.
The Gardasil vaccine is indicated for use in girls and women aged 9 to 45 years to prevent diseases caused by HPV types 6, 11, 16, 18, including:
Gardasil is also indicated for use in boys and men ages 9 to 26 to prevent diseases and infections caused by HPV types 6, 11, 16, and 18.
Hypersensitivity to the active substances or to any component of the vaccine, including severe allergic reactions to yeast.
In individuals who develop symptoms suggestive of hypersensitivity after administration of a dose of Gardasil, administration of the next dose of vaccine is contraindicated.
As with other vaccines, the use of Gardasil should be delayed if the patient has an acute illness accompanied by fever. The presence of a mild infection, such as a minor upper respiratory tract infection or a low-grade fever, is not a contraindication to vaccination.
Possible side effects:
Serious complications are extremely rare (anaphylactic reactions, bronchospasm, urticaria, convulsions).
Not available